Laboratory Testing in the Treatment of HCV: New Drugs, New Tests, New Rules



About this Webinar

Date: Monday, April 16, 2012

Author: Dieterich, Douglas, MD
Professor of Medicine, Division of Liver Diseases
Mount Sinai School of Medicine
New York, NY
Also by this Author 

Category: Webinar

Description: Douglas T. Dieterich, MD discusses which will focus on current guidelines and recommended strategies for treating patients with chronic hepatitis C viral (HCV) infection, including protease inhibitors and response-guided therapy, HCV RNA assays, IL28B genotyping and resistance testing.

Learning objectives: at the conclusion of this activity, participants will be able to:

o Discuss the epidemiology and current disease trends for hepatitis C infection in the United States
o Communicate current treatment guidelines and recommended strategies for treating HCV, including newly developed protease inhibitors
o Describe recommended laboratory testing for screening and managing patients with HCV